Multinational Australian labs group Sonic is acquiring regional German labs group Medical Laboratories Duesseldorf (MLD), in its second acquisition in the sector in the space of one month.
Listed UK-based teleradiology provider Medica is being taken private by PE firm IK Investment Partners, which has made an offer of £269m to buy all of the group’s shares. Medica has accepted the offer, which was 32.4% higher than the group’s average market cap over the past three months.
Multinational Swiss labs giant Unilabs is consolidating its position in the Dutch labs market by acquiring Atalmedial, one of the largest national players.
Singaporean state-owned investment conglomerate Temasek is to become majority shareholder in Manipal Hospitals, one of India’s largest hospital chains, as it increases its stake from 18% to 59%.
Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion.
It has been almost two years since listed Germany-based healthcare property specialist Vonovia acquired its former rival Deutsche Wohnen. We speak to three Germany-based experts to find about more about the ongoing sale of its £1.3bn property portfolio.
Last week we wrote about an expected return to normal of M&A deal activity in Europe in Q2, after a slow few months driven by macroeconomic uncertainty. In South East Asia deal activity already appears to be returning to a healthier level, with multiple $1bn+ deals reportedly underway.
Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
Multinational Australian labs giant Sonic is buying Diagnosticum, a medium-sized German labs chain which operates 15 laboratories and employs 25 pathologists, for €190m.
